K2M
Company

Last deal

$40M

Amount

Post-IPO Equity

Stage

22.01.2015

Date

1

all rounds

$40M

Total amount

General

About Company
K2M Group Holdings is a global medical device company that designs, develops, and commercializes spine technologies and techniques.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2004

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's spine products, including implants, disposables, and instruments, are used by spine surgeons to treat complex spinal pathologies such as deformity, trauma, and tumor. K2M Group Holdings markets and sells its products in the United States and 28 other countries, with a focus on achieving three-dimensional Total Body Balance through its Balance ACS platform of products, services, and research. The company also invests in the design, development, and commercialization of new solutions for unmet clinical needs in the complex spine and minimally invasive spine markets.
Contacts

Social url